IPOs under microscope as Chr Hansen and Life get ready

27 May 2010

The EMEA IPO market will face a stern test next week when Danish biotech firm Chr Hansen and South African healthcare group Life price their IPOs, which together hope to raise around $1.8bn.

No deals were due to be priced this week so Europe was spared an IPO wipeout as markets swung wildly. The EuroStoxx 50 index went from 2,764.31 on May 12 to 2,488.50 on Tuesday — a fall of 10% — before recovering later during the week to close ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial